Callan Family Office’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Sell
22,307
-493
-2% -$28.5K 0.02% 592
2026
Q1
$1.5M Buy
22,800
+7,697
+51% +$402K 0.03% 438
2025
Q4
$639K Sell
15,103
-11,352
-43% -$463K 0.01% 693
2025
Q3
$1.11M Sell
26,455
-1,683
-6% -$83.8K 0.04% 357
2025
Q2
$1.56M Buy
28,138
+19,752
+236% +$984K 0.05% 304
2025
Q1
$476K Buy
8,386
+3,035
+57% +$190K 0.04% 337
2024
Q4
$370K Buy
+5,351
New +$514K 0.02% 434
2023
Q2
– Sell
-3,967
Closed -$432K – 118
2023
Q1
$432K Buy
+3,967
New +$458K 0.1% 101

Other funds holding CE

Callan Family Office's CE Position: Q2 2026 in Review

Callan Family Office reduced its Celanese (CE) stake by 2.2% in Q2 2026, selling an estimated $28.5K and leaving 22,307 shares worth $1.03M. The position accounts for 0.02% of the portfolio, ranked #592.

Callan Family Office first reported a position in CE in Q1 2023 and has held it in 8 quarters since. The position peaked at $1.56M in Q2 2025. 460 funds tracked by Wall St. Rank hold CE as of Q2 2026.

  • Callan Family Office held 22,307 shares of Celanese worth $1.03M as of Q2 2026.
  • Callan Family Office sold 493 Celanese shares in Q2 2026, an estimated $28.5K.
  • Celanese made up 0.02% of Callan Family Office's portfolio in Q2 2026, its #592 holding.
  • Callan Family Office first reported a position in Celanese in Q1 2023 and has held it in 8 quarters since.
  • Callan Family Office's Celanese position peaked at $1.56M in Q2 2025.
  • 460 funds tracked by Wall St. Rank held Celanese as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.